World

Top 946 largest Companies in the Biotechnology industry in the World by Market Cap

This is the list of the largest public listed companies in the Biotechnology industry in the world by market capitalization with links to their reference stock.

World Biotechnology Industry Analysis
World Top Companies World Companies Analysis

Top Biotechnology Companies in the World as of Jan. 01, 2026

Rank Company Market Cap (USD) Country Sector Industry
31 Moderna, Inc. $12.06 B United States US Healthcare US Biotechnology
32 Karuna Therapeutics, Inc. $11.94 B

(Jan. 1, 2024)

 United States US Healthcare US Biotechnology
33 Exelixis, Inc. $11.73 B United States US Healthcare US Biotechnology
34 BioMarin Pharmaceutical Inc. $11.42 B United States US Healthcare US Biotechnology
35 Financière de Tubize SA $11.03 B Belgium Belgian Healthcare Belgian Biotechnology
36 Avidity Biosciences, Inc. $10.86 B United States US Healthcare US Biotechnology
37 Acceleron Pharma Inc. $10.56 B

(Nov. 1, 2021)

 United States US Healthcare US Biotechnology
38 ABIVAX SA $10.53 B France French Healthcare French Biotechnology
39 Jazz Pharmaceuticals plc $10.52 B Ireland Irish Healthcare Irish Biotechnology
40 Zealand Pharma A/S $9.64 B

(July 1, 2024)

 Denmark Danish Healthcare Danish Biotechnology
41 3SBio, Inc. $9.48 B China Chinese Healthcare Chinese Biotechnology
42 Arrowhead Pharmaceuticals, Inc. $9.37 B United States US Healthcare US Biotechnology
43 Bio-Techne Corporation $9.29 B United States US Healthcare US Biotechnology
44 Axsome Therapeutics, Inc. $9.01 B United States US Healthcare US Biotechnology
45 OncBioMune Pharmaceuticals, Inc. $8.67 B

(Feb. 1, 2022)

 United States US Healthcare US Biotechnology
46 Blueprint Medicines Corporation $8.30 B

(July 1, 2025)

 United States US Healthcare US Biotechnology
47 Beijing Wantai Biological Pharmacy Enterprise Co. Ltd $8.28 B China Chinese Healthcare Chinese Biotechnology
48 Halozyme Therapeutics, Inc. $8.27 B United States US Healthcare US Biotechnology
49 ImmunoGen, Inc. $8.25 B

(Jan. 1, 2024)

 United States US Healthcare US Biotechnology
50 Hebei Changshan Biochemical Pharmaceutical Co. Ltd $8.05 B China Chinese Healthcare Chinese Biotechnology
51 Verona Pharma plc $7.78 B

(July 1, 2025)

 United Kingdom UK Healthcare UK Biotechnology
52 Cytokinetics, Incorporated $7.55 B United States US Healthcare US Biotechnology
53 Cerevel Therapeutics Holdings, Inc. $7.46 B

(July 1, 2024)

 United States US Healthcare US Biotechnology
54 Praxis Precision Medicines, Inc. $7.16 B United States US Healthcare US Biotechnology
55 Krystal Biotech, Inc. $7.16 B United States US Healthcare US Biotechnology
56 RemeGen Co. Ltd $7.11 B China Chinese Healthcare Chinese Biotechnology
57 Rhythm Pharmaceuticals, Inc. $7.01 B United States US Healthcare US Biotechnology
58 Cidara Therapeutics, Inc. $6.95 B United States US Healthcare US Biotechnology
59 Merus N.V. $6.83 B Netherlands Dutch Healthcare Dutch Biotechnology
60 SK Biopharmaceuticals Co. Ltd $6.67 B South Korea South Korean Healthcare South Korean Biotechnology

Top Biotechnology Companies in the World as of Jan. 01, 2026

31. Moderna, Inc.

Company Profile: Moderna, Inc.
Market Cap (USD): $12.06 B
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

32. Karuna Therapeutics, Inc.

Company Profile: Karuna Therapeutics, Inc.
Market Cap (USD): $11.94 B (Jan. 1, 2024)
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

33. Exelixis, Inc.

Company Profile: Exelixis, Inc.
Market Cap (USD): $11.73 B
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

34. BioMarin Pharmaceutical Inc.

Company Profile: BioMarin Pharmaceutical Inc.
Market Cap (USD): $11.42 B
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

35. Financière de Tubize SA

Company Profile: Financière de Tubize SA
Market Cap (USD): $11.03 B
Country: Belgium
Sector: Belgian Healthcare
Industry: Belgian Biotechnology

36. Avidity Biosciences, Inc.

Company Profile: Avidity Biosciences, Inc.
Market Cap (USD): $10.86 B
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

37. Acceleron Pharma Inc.

Company Profile: Acceleron Pharma Inc.
Market Cap (USD): $10.56 B (Nov. 1, 2021)
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

38. ABIVAX SA

Company Profile: ABIVAX SA
Market Cap (USD): $10.53 B
Country: France
Sector: French Healthcare
Industry: French Biotechnology

39. Jazz Pharmaceuticals plc

Company Profile: Jazz Pharmaceuticals plc
Market Cap (USD): $10.52 B
Country: Ireland
Sector: Irish Healthcare
Industry: Irish Biotechnology

40. Zealand Pharma A/S

Company Profile: Zealand Pharma A/S
Market Cap (USD): $9.64 B (July 1, 2024)
Country: Denmark
Sector: Danish Healthcare
Industry: Danish Biotechnology

41. 3SBio, Inc.

Company Profile: 3SBio, Inc.
Market Cap (USD): $9.48 B
Country: China
Sector: Chinese Healthcare
Industry: Chinese Biotechnology

42. Arrowhead Pharmaceuticals, Inc.

Company Profile: Arrowhead Pharmaceuticals, Inc.
Market Cap (USD): $9.37 B
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

43. Bio-Techne Corporation

Company Profile: Bio-Techne Corporation
Market Cap (USD): $9.29 B
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

44. Axsome Therapeutics, Inc.

Company Profile: Axsome Therapeutics, Inc.
Market Cap (USD): $9.01 B
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

45. OncBioMune Pharmaceuticals, Inc.

Company Profile: OncBioMune Pharmaceuticals, Inc.
Market Cap (USD): $8.67 B (Feb. 1, 2022)
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

46. Blueprint Medicines Corporation

Company Profile: Blueprint Medicines Corporation
Market Cap (USD): $8.30 B (July 1, 2025)
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

47. Beijing Wantai Biological Pharmacy Enterprise Co. Ltd

Company Profile: Beijing Wantai Biological Pharmacy Enterprise Co. Ltd
Market Cap (USD): $8.28 B
Country: China
Sector: Chinese Healthcare
Industry: Chinese Biotechnology

48. Halozyme Therapeutics, Inc.

Company Profile: Halozyme Therapeutics, Inc.
Market Cap (USD): $8.27 B
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

49. ImmunoGen, Inc.

Company Profile: ImmunoGen, Inc.
Market Cap (USD): $8.25 B (Jan. 1, 2024)
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

50. Hebei Changshan Biochemical Pharmaceutical Co. Ltd

Company Profile: Hebei Changshan Biochemical Pharmaceutical Co. Ltd
Market Cap (USD): $8.05 B
Country: China
Sector: Chinese Healthcare
Industry: Chinese Biotechnology

51. Verona Pharma plc

Company Profile: Verona Pharma plc
Market Cap (USD): $7.78 B (July 1, 2025)
Country: United Kingdom
Sector: UK Healthcare
Industry: UK Biotechnology

52. Cytokinetics, Incorporated

Company Profile: Cytokinetics, Incorporated
Market Cap (USD): $7.55 B
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

53. Cerevel Therapeutics Holdings, Inc.

Company Profile: Cerevel Therapeutics Holdings, Inc.
Market Cap (USD): $7.46 B (July 1, 2024)
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

54. Praxis Precision Medicines, Inc.

Company Profile: Praxis Precision Medicines, Inc.
Market Cap (USD): $7.16 B
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

55. Krystal Biotech, Inc.

Company Profile: Krystal Biotech, Inc.
Market Cap (USD): $7.16 B
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

56. RemeGen Co. Ltd

Company Profile: RemeGen Co. Ltd
Market Cap (USD): $7.11 B
Country: China
Sector: Chinese Healthcare
Industry: Chinese Biotechnology

57. Rhythm Pharmaceuticals, Inc.

Company Profile: Rhythm Pharmaceuticals, Inc.
Market Cap (USD): $7.01 B
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

58. Cidara Therapeutics, Inc.

Company Profile: Cidara Therapeutics, Inc.
Market Cap (USD): $6.95 B
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

59. Merus N.V.

Company Profile: Merus N.V.
Market Cap (USD): $6.83 B
Country: Netherlands
Sector: Dutch Healthcare
Industry: Dutch Biotechnology

60. SK Biopharmaceuticals Co. Ltd

Company Profile: SK Biopharmaceuticals Co. Ltd
Market Cap (USD): $6.67 B
Country: South Korea
Sector: South Korean Healthcare
Industry: South Korean Biotechnology

Stay in touch